Which treatment option is NOT indicated in managing acute bronchiolitis?

In managing acute bronchiolitis, the use of topical steroids is not indicated. Acute bronchiolitis is primarily caused by viral infections, most commonly respiratory syncytial virus (RSV), and its management focuses on supportive care to relieve symptoms.

Supportive care includes ensuring that the child remains hydrated, monitoring oxygen saturation levels, and providing supplemental oxygen if needed. Oxygen therapy is used when there is evidence of hypoxia. Bronchodilators are sometimes administered, although their efficacy can vary and they are generally not a primary treatment modality.

Topical steroids, on the other hand, have not demonstrated benefits in treating bronchiolitis and could potentially introduce unnecessary risks and side effects. Thus, their use is not considered appropriate in the acute management of this condition.